The American Heart Association/American Stroke Association International Stroke Conference
USPSTF Updates Guidance on Statins for Primary Prevention of CVD
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
New Billing Guidelines Do Not Ease Burden of EHR Documentation
Implementation of new guidelines did affect distribution of levels of service billed for evaluation and management patient visits
HTN Risk Increased for Women Who Experience Sexual Violence
Women who experienced both sexual assault and workplace sexual harassment had highest risk for developing hypertension
Bridging Therapy May Be Better for Large Vessel Occlusion Stroke
Better outcomes associated with IV thrombolysis followed by mechanical thrombectomy versus mechanical thrombectomy alone
High-Volume Surgeons Key to Survival in Open Repair for AAA
Surgeons with at least seven open aortic procedures per year, centers with perioperative mortality rate ≤5 percent tied to better outcomes
Physical Activity in Early Late Life May Cut Risk for CVD
At least 20 minutes a day of physical activity early in late life associated with the greatest cardiovascular benefits
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
SGLT2is, SGLT2i/GLP-1RA May Prevent CV Events in T2DM
Current use of SGLT2is, GLP-1RAs, and their combination associated with significantly reduced risk of heart failure events